Poolbeg Pharma (POLB), a biopharmaceutical company, announces that, further to its announcement in July 2022, it has now received the initial results having completed the Lipopolysaccharide human challenge clinical trial
Poolbeg Pharma (POLB), a biopharmaceutical company, announces that, further to its announcement in July 2022, it has now received the initial results having completed the Lipopolysaccharide human challenge clinical trial
Open Orphan (ORPH), a specialist contract research organisation, noted a key considerations document for developing and manufacturing challenge agents published in the Wellcome Open Research Journal co-authored by Alex Mann,
African Pioneer (AFP), the exploration and resource development company, updated on the 85% owned Ongombo Copper Mine Project situated in Namibia, where a Mining Licence Application has been submitted to
The latest from Xtract Resources (XTR) takes us away from Bushranger as it announced the preliminary unaudited results for alluvial mining contractors for the Manica Concession for the three-month period
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Crypto VC and Tech Company Rockets to $50m AUM Within 50 Days of Inception
It is now a couple of weeks since I wrote about the impending furlough crisis and the horrific consequences that lie in wait for unemployment, as well as the social
FAANGS
Welcome to the next generation of trade finance.
Much has been written over the last few years about the slow destruction of the quoted plc as a mainstay of the western capitalist system.